Home » Prices » NASDAQ:CDXC

ChromaDex Corporation stock price

Today's NASDAQ:CDXC chart, history & news

Price:
5.00 USD
Change:
+0.04 (0.81%)
Key Stats
Price open
Previous close 4.96
Market cap 308.94M
Volume 235.96K
Day high 5.01
Day low 4.86
Year high 5.56
Year low 2.54
Year to date change 15.89%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About ChromaDex Corporation

ChromaDex is a dietary supplement and food ingredient company based in Los Angeles, California founded in 1999 that is publicly traded on the NASDAQ. In 2011, Dartmouth College announced it granted ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside which it markets and sells as an ingredient under the brand name Tru Niagen. The firm also offers contract research services for sourcing raw materials, identifying new compounds, and developing processes for large scale manufacturing. ChromaDex licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound trademarked as pTeroPure via the company's BluScience product line. ChromaDex no longer sells PteroPure.

Company information

Company name
Chromadex Corp
Exchange
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Robert Fried
Address
10900 Wilshire Blvd Ste 600, Los angeles, California, 90024-6534
Country
United States
Contact information
13103886706
Website
https://chromadex.com/default.aspx

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.